Puerarin protects against staphylococcus aureus-induced injury of human alveolar epithelial A549 cells via downregulating alpha-hemolysin secretion

Microbial Drug Resistance

Volumn 20, Issue 4, 2014, Pages 357-363

  Tang, Feng ^a   Li, Wen Hua ^b   Zhou, Xuan ^b   Liu, Yong Hua ^a   Li, Zhe ^c   Tang, Yu Shun ^a   Kou, Xu ^a   Wang, Shu De ^a   Bao, Min ^a   Qu, Lian Da ^a   Li, Min ^a   Li, Bing ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c Jinnan Develop and Service Center of Animal Husbandry and Aquaculture   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; PUERARIN; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; HEMOLYSIN; ISOFLAVONE DERIVATIVE; PLANT EXTRACT; STAPHYLOCOCCAL ALPHA-TOXIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL PROTECTION; DOWN REGULATION; GENE EXPRESSION; HEMOLYSIS; HLA SYSTEM; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG EFFECTS; EPITHELIUM CELL; ERYTHROCYTE; ISOLATION AND PURIFICATION; MEDICINAL PLANT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; RABBIT; RESPIRATORY TRACT MUCOSA; SECRETION (PROCESS);

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CELL LINE; EPITHELIAL CELLS; ERYTHROCYTES; HEMOLYSIN PROTEINS; HEMOLYSIS; HUMANS; ISOFLAVONES; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANTS, MEDICINAL; RABBITS; RESPIRATORY MUCOSA; STAPHYLOCOCCUS AUREUS;

EID: 84905192740     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2013.0104     Document Type: Article

References (31)

1. Bebrevska, L., K. Foubert, N. Hermans, S. Chatterjee, E. Van Marck, G. De Meyer, A. Vlietinck, L. Pieters, and S. Apers. 2010. In vivo antioxidative activity of a quantified pueraria lobata root extract. J. Ethnopharmacol. 127:112-117.
2. Borde, J.P., and W.V. Kern. 2012. Treatment of mrsa infections. Dtsch. Med. Wochensch. 137:2553-2557.
3. Bubeck Wardenburg, J., R.J. Patel, and O. Schneewind. 2007. Surface proteins and exotoxins are required for the pathogenesis of staphylococcus aureus pneumonia. Infect. Immun. 75:1040-1044.
4. Bubeck Wardenburg, J., and O. Schneewind. 2008. Vaccine protection against staphylococcus aureus pneumonia. J. Exp. Med. 205:287-294.
5. Cain, C.L. 2013. Antimicrobial resistance in staphylococci in small animals. The Veterinary clinics of North America. Small Anim. Pract. 43:19-40.
6. Callegan, M.C., L.S. Engel, J.M. Hill, and R.J. Ocallaghan. 1994. Corneal virulence of staphylococcus aureus: roles of alpha-toxin and protein a in pathogenesis. Infect. Immun. 62:2478-2482.
7. Cegelski, L., G.R. Marshall, G.R. Eldridge, and S.J. Hultgren. 2008. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6:17-27.
8. Clatworthy, A.E., E. Pierson, and D.T. Hung. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3:541-548.
9. Goyal, N., A. Miller, M. Tripathi, and J. Parvizi. 2013. Methicillin-resistant staphylococcus aureus (mrsa): colonisation and pre-operative screening. Bone Joint J. 95-B:4-9.
10. Hume, E.B., J.J. Dajcs, J.M. Moreau, and R.J. Ocallaghan. 2000. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental staphylococcus aureus keratitis. Infec. Immun. 68:6052-6055.
11. Khaziev, A.F., N.A. Mikhailova, and L.P. Blinkova. 2006. [Interaction of staphylococcus aureus alpha-toxin with eukaryotic cells and their target]. Zh. Mikrobiol. Epidemiol. Immunobiol. 2: 110-114.
12. Kielian, T., A. Cheung, and W.F. Hickey. 2001. Diminished virulence of an alpha-toxin mutant of staphylococcus aureus in experimental brain abscesses. Infect. Immun. 69:6902-6911.
13. Liang, X., and Y. Ji. 2007. Involvement of alpha5beta1-integrin and tnf-alpha in staphylococcus aureus alphatoxin-induced death of epithelial cells. Cell. Microbiol. 9: 1809-1821.
14. Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
15. Mcgahee, W., and F.D. Lowy. 2000. Staphylococcal infections in the intensive care unit. Semin. Respir. Infect. 15:308-313.
16. Menzies, B.E., and D.S. Kernodle. 1996. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from staphylococcus aureus is protective in a murine model. Infect. Immun. 64:1839-1841.
17. Nilsson, I. M., O. Hartford, T. Foster, and A. Tarkowski. 1999. Alpha-toxin and gamma-toxin jointly promote staphylococcus aureus virulence in murine septic arthritis. Infect. Immun. 67:1045-1049.
18. Otto, M. 2012. Mrsa virulence and spread. Cell. Microbiol. 14:1513-1521.
19. Patel, A.H., P. Nowlan, E.D. Weavers, and T. Foster. 1987. Virulence of protein a-deficient and alpha-toxindeficient mutants of staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:3103-3110.
20. Qiu, J.,X.Niu, J.Dong,D.Wang, J.Wang,H.Li,M.Luo, S. Li, H. Feng, and X. Deng. 2012. Baicalin protects mice from staphylococcus aureus pneumonia via inhibition of the cytolytic activity of alpha-hemolysin. J. Infect. Dis. 206:292-301.
21. Qiu, J., J. Wang, H. Luo, X. Du, H. Li, M. Luo, J. Dong, Z. Chen, and X. Deng. 2011. The effects of subinhibitory concentrations of costus oil on virulence factor production in staphylococcus aureus. J. Appl. Microbiol. 110:333-340.
22. Rasko, D.A., and V. Sperandio. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9:117-128.
23. Recsei, P., B. Kreiswirth, M. Oreilly, P. Schlievert, A. Gruss, and R.P. Novick. 1986. Regulation of exoprotein gene expression in staphylococcus aureus by agar. Mol. Gen. Genet. 202:58-61.
24. Rubinstein, E., M.H. Kollef, and D. Nathwani. 2008. Pneumonia caused by methicillin-resistant staphylococcus aureus. Clin. Infect. Dis. 46 Suppl 5:S378-S385.
25. Wang, J., J. Qiu, J. Dong, H. Li, M. Luo, X. Dai, Y. Zhang, B. Leng, X. Niu, S. Zhao, and X. Deng. 2011. Chrysin protects mice from staphylococcus aureus pneumonia. J. Appl. Microbiol. 111:1551-1558.
26. Wang, Y., L. Yin, Y. Li, P. Liu, and Q. Cui. 2008. Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin. Orthop. Relat. Res. 466:1059-1067.
27. Watkins, R.R., M.Z. David, and R.A. Salata. 2012. Current concepts on the virulence mechanisms of meticillin-resistant staphylococcus aureus. J. Med. Microbiol. 61:1179-1193.
28. Worlitzsch, D., H. Kaygin, A. Steinhuber, A. Dalhoff, K. Botzenhart, and G. Doring. 2001. Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of staphylococcus aureus in vitro and in vivo. Antimicrob. Agents Chemother. 45:196-202.
29. Xiao, C., J. Li, X. Dong, X. He, X. Niu, C. Liu, G. Zhong, R. Bauer, D. Yang, and A. Lu. 2011. Anti-oxidative and tnf-alpha suppressive activities of puerarin derivative (4ac) in raw264.7 cells and collagen-induced arthritic rats. Eur. J. Pharmacol. 666:242-250.
30. Xiong, F.L., X.H. Sun, L. Gan, X.L. Yang, and H.B. Xu. 2006. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur. J. Pharmacol. 529:1-7.
31. Zhang, Y., J.F. Wang, J. Dong, J.Y. Wei, Y.N. Wang, X.H. Dai, X. Wang, M.J. Luo, W. Tan, X.M. Deng, and X.D. Niu. 2013. Inhibition of alpha-toxin production by subinhibitory concentrations of naringenin controls staphylococcus aureus pneumonia. Fitoterapia 86:92-99.